Company Information

Headquarters
United States
Founded in
2006
Employees
51 - 200( View All )
Speciality
-
Overview
Raptor Pharmaceutical Corp. is a global biopharmaceutical company focused on the development and commercialization of life-altering therapeutics that treat rare, debilitating and often fatal diseases. The company is engaged in multiple therapeutic areas such as nephropathic cystinosis, Huntington’s disease (HD), and mitochondrial diseases including Leigh’s syndrome. Raptor holds several orphan drug designations, including orphan drug exclusivity for nephropathic cystinosis in the U.S. and EU, and orphan drug designation for HD in the U.S. and EU. Raptor holds intellectual property for the use of cysteamine in HD and other neurodegenerative disorders including Parkinson’s disease and Rett syndrome. We are headquartered in Novato, CA, and are always looking for innovative and passionate individuals to join our team! For additional information about the company, or if you are interested in a career at Raptor, please visit our website: http://www.raptorpharma.com
search

Sign Up to View Raptor Pharmaceuticals’s Top Employees

Instant access. Cancel anytime

Similar Companies

Start with AroundDeal For Free!

Use AroundDeal to build prospect lists in 1 click.

Instant access. Cancel anytime

Get Contact Info for All Employees

Employees:

static-employee
Ben Cadieux

Sr. Director, Clinical Development

static-employee
Carmen Enciu

Vice President, Global Medical Affairs

static-employee
Betania Glorio

Director, EU Compliance Operations


static-employee
Maria Lucia Pecoraro

Senior Director, Clinical Development

static-employee
Patrick Droesch

Regional Business Manager